osudhkosh

Benkinson 62.550mg+12.5mg

Rx
Dosage form:
Capsule
Pack size:
Strip (10 Capsule)
Save to my medicines
Alert me on price drop

৳ 8/unit

Pack: ৳ 80

Price comparison

This brand
8

This is the cheapest brand of this generic

Compared against 1 brands

At a glance

Levodopa + Benserazide is used in the treatment of Parkinson's disease. Levodopa is a dopamine precursor that crosses the blood-brain barrier and is converted to dopamine in the brain. Benserazide is a peripheral decarboxylase inhibitor that reduces peripheral metabolism of levodopa, allowing more levodopa to reach the brain.

Indications
  • Parkinson's disease - Immediate Release capsule: all forms except drug-induced Parkinsonism
  • Parkinson's disease - Controlled Release capsule: patients with motor fluctuations, especially peak dose dyskinesia and end of dose deterioration and for better control of nocturnal symptoms
Dosage

Immediate Release IR Capsule:

  • Patients not receiving levodopa: Early stage: 50+12.5 62.5 mg, 1-2 times/day; gradually increase by 62.5 mg every 3-4 days
  • Adult: 50+12.5 62.5 mg, 3-4 times/day OR Advanced stage: 100+25 125 mg, 3 times/day
  • Maintenance: 100+25 125 mg, up to 3-6 times/day
  • Previous levodopa monotherapy: Initiate with 10-15% of previous dose
  • Previous other levodopa/dopa decarboxylase combination: Withdraw previous therapy for 12 hours, start 50+12.5 62.5 mg, 3-4 times/day

Controlled Release CR Capsule:

  • Patients not receiving levodopa: 100+25 125 mg, 3 times/day; maximum 6 capsules/day
  • Previous levodopa-benserazide IR: Substitute every 100 mg levodopa with 1 CR capsule; increase every 2-3 days
Side effects

Common Side Effects:

  • Anxiety, decreased appetite
  • Arrhythmia
  • Depression
  • Diarrhea
  • Hallucinations
  • Movement disorders dyskinesia
  • Nausea
  • Postural hypotension
  • Sleep disorders
  • Altered taste
  • Vomiting
  • Leucopenia
Precautions & warnings
  • Reduce dose if dyskinesia occurs early
  • Caution with orthostatic hypotension
  • Caution in psychiatric illness, diabetes, cardiovascular disease, peptic ulcer, glaucoma, pheochromocytoma
  • Caution in Cushing's syndrome, endocrine disorders, hyperthyroidism, osteomalacia
  • May activate malignant melanoma - do not use in suspicious lesions or history of melanoma
Levodopa + Benserazide — see the full informationPharmacology, precautions, pregnancy, overdose and the rest on the generic page
⚠️ This information is for educational purposes only — not a substitute for medical advice. Consult a registered physician before taking any medicine.